NF2-_SC-CRISPR-S7 drug treatment.xlsx

syn30384771

Created By Roberta Beauchamp Beauchamp

Uuid: c2ca2de3-6c1f-4e8d-bc0b-8901da7092c8
assay: cell viability assay
organ:
ageUnit:
species: Homo sapiens
studyId: syn27761862
cellType: schwann
comments: data represents dose response of cell lines to drug treatment (expressed as % viability) in drug treated cells compared to DMSO control treatment
dataType: drug screen
entityId: syn30384771
platform: EnVision 2103 Multiplate Reader
Component: PlateBasedReporterAssayTemplate
aliquotID:
diagnosis:
studyName: Leveraging Synodos NF2 data to test novel single and combination drugs in NF2-deficient meningioma models
tumorType:
initiative: Drug Discovery Initiative Registered Reports
isCellLine: Yes
specimenID:
dataSubtype: processed
nf2Genotype: -/-
reporterGene:
resourceType: experimentalData
fundingAgency: CTF
isPrimaryCell: No
timePointUnit: hours
platformTarget:
modelSystemName: hTERT NF1 ipn02.3 2λ
parentSpecimenID:
reporterSubstance:
progressReportNumber: 10
experimentalCondition: drug treated vs DMSO
experimentalTimepoint: 72
specimenPreparationMethod:

NF2-_SC-CRISPR-S7 drug treatment.xlsx page is loading…